Overview ERKNet Guideline Projects
Collaboration | Status | WG | |
ESPN | EJHG 2020 | Hereditary GP | |
eUROGEN | KI 2021 | Metabolic nephropathies | |
NRN 2021 | Tubulopathies | ||
ESPN | NDT 2021 | Tubulopathies | |
ERA-EDTA | NDT 2021 | Taskforce molecular diagnostics | |
NDT 2022 | Congenital malformations & Ciliopathies | ||
eUROGEN | Nat Rev Urol 2022 | Obstructive uropathies | |
ERA/Polycystic Kidney Disease International | NDT 2022 | AD structural disorders | |
CERTAIN | Pediatric Transplantation 2021 | Pediatric transplantation | |
Hyperoxaluria | OxalEurope | In submission | Metabolic nephropathies |
Monoclonal gammopathies of renal significance | EuroBloodNet | Paper in preparation | Immune GP |
Dent´s disease | Under development | Metabolic nephropathies | |
Nephrogenic diabetes insipidus | Under development | Tubulopathies | |
Tuberous Sclerosis Complex |
| Under development | AD structural disorders |
Bardet-Biedl Syndrome | ERN-Eye | Under development | Renal malformations |
Methylmalonic acidemia | MetabERN | Under development | Metabolic nephropathies |
Lipid apheresis |
| Under development | Pediatric CKD/Dialysis |
Renal hypomagnesemia | ESPN/ERA | In planning | Tubulopathies |
Lowe syndrome | In planning | Metabolic nephropathies | |
Alport syndrome | In planning | Hereditary Glomerulopathies | |
IgA nephropathy in children | IPNA | In planning | Immune GP |
Consensus paper on genetic testing in adult patients; what are the pros and cons; when and why? |
| In planning | Immune GP |
Renal amyloidosis |
| In planning | Immune GP |
Cryoglobulinemic glomerulonephritis |
| In planning | Immune GP |
ACEi/ARB in CKD |
| In planning | Pediatric CKD/Dialysis |
Cardiovascular evaluation and management in pediatric CKD | WG Dialysis and Tx | In planning | Pediatric CKD/Dialysis |
Practical guideline on treatment of STEC-HUS’ |
| In planning | TMA |